-
1
-
-
0017652462
-
Memory and cognitive function in man: Does the cholinergic system have a specific role?
-
Drachman DA. Memory and cognitive function in man: does the cholinergic system have a specific role? Neurology 1977; 27: 783-90.
-
(1977)
Neurology
, vol.27
, pp. 783-790
-
-
Drachman, D.A.1
-
2
-
-
0011162190
-
Selective loss of central cholinergic neurons in Alzheimer's disease
-
Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976; 2: 1403.
-
(1976)
Lancet
, vol.2
, pp. 1403
-
-
Davies, P.1
Maloney, A.J.2
-
3
-
-
0020686674
-
Alzheimer's disease: A disorder of cholinergic innervation
-
Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of cholinergic innervation. Science 1983; 219: 1184-90.
-
(1983)
Science
, vol.219
, pp. 1184-1190
-
-
Coyle, J.T.1
Price, D.L.2
DeLong, M.R.3
-
4
-
-
0032296920
-
Tratamiento médico de la enfermedad de Alzheimer
-
López-Pousa S, Serra-Mestres J. Tratamiento médico de la enfermedad de Alzheimer. Rev Neurol 1998; 26: 1054-60.
-
(1998)
Rev Neurol
, vol.26
, pp. 1054-1060
-
-
López-Pousa, S.1
Serra-Mestres, J.2
-
6
-
-
0018078940
-
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
-
Perry EK, Tomlinson BE, Blessed G, Bergman K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 1978; 2: 1457-9.
-
(1978)
Br Med J
, vol.2
, pp. 1457-1459
-
-
Perry, E.K.1
Tomlinson, B.E.2
Blessed, G.3
Bergman, K.4
Gibson, P.H.5
Perry, R.H.6
-
7
-
-
0028238408
-
Emerging drugs for Alzheimer's disease: Mechanisms of actions and prospects for cognitive enhancing medications
-
Schneider LS, Tariot PN. Emerging drugs for Alzheimer's disease: mechanisms of actions and prospects for cognitive enhancing medications. Med Clin North Am 1994; 78: 911-34.
-
(1994)
Med Clin North Am
, vol.78
, pp. 911-934
-
-
Schneider, L.S.1
Tariot, P.N.2
-
8
-
-
0022899577
-
Oral tetrahydroaminoacridine in long-term treatment of senile dementia Alzheimer type
-
Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia Alzheimer type. N Engl J Med 1986; 315: 1241-5.
-
(1986)
N Engl J Med
, vol.315
, pp. 1241-1245
-
-
Summers, W.K.1
Majovski, L.V.2
Marsh, G.M.3
Tachiki, K.4
Kling, A.5
-
9
-
-
0028270519
-
A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease
-
Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davies CS, Gracon SI. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994; 271: 985-91.
-
(1994)
JAMA
, vol.271
, pp. 985-991
-
-
Knapp, M.J.1
Knopman, D.S.2
Solomon, P.R.3
Pendlebury, W.W.4
Davies, C.S.5
Gracon, S.I.6
-
10
-
-
0028198828
-
Tacrine: First drug approved for Alzheimer's disease
-
Crismon ML. Tacrine: first drug approved for Alzheimer's disease. Ann Pharmacother 1994; 28: 744-51.
-
(1994)
Ann Pharmacother
, vol.28
, pp. 744-751
-
-
Crismon, M.L.1
-
11
-
-
10244259208
-
The efficacy and safety of donepezil in patients with Alzheimer's disease: Re-suits of a US multicenter, randomized, double-blind, placebo-controlled trial
-
Rogers SL, Friedhoff LT, and The Donepezil Study Group. The efficacy and safety of donepezil in patients with Alzheimer's disease: re-suits of a US multicenter, randomized, double-blind, placebo-controlled trial. Dementia 1996; 7: 293-303.
-
(1996)
Dementia
, vol.7
, pp. 293-303
-
-
Rogers, S.L.1
Friedhoff, L.T.2
-
12
-
-
0032507788
-
Donepezil improves cognition and global function in Alzheimer disease: A 15-week, doubled-blind, placebo-controlled study
-
Donepezil Study Group
-
Rogers SL, Doody RS, Mohs RC, Friedhoff LT. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, doubled-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med 1998; 158: 1021-31.
-
(1998)
Arch Intern Med
, vol.158
, pp. 1021-1031
-
-
Rogers, S.L.1
Doody, R.S.2
Mohs, R.C.3
Friedhoff, L.T.4
-
13
-
-
0031883716
-
A 24-week, double blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
-
Donepezil Study Group
-
Rogers SL, Farlow MR, Doody RS, Mohs RC, Friedhoff LT. A 24-week, double blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology 1998; 50: 136-45.
-
(1998)
Neurology
, vol.50
, pp. 136-145
-
-
Rogers, S.L.1
Farlow, M.R.2
Doody, R.S.3
Mohs, R.C.4
Friedhoff, L.T.5
-
14
-
-
0028823072
-
Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-((5,6-dimethoxy-1-oxoindan-2-ye)methyl)piperidine hydrochloride and related compounds
-
Sugimoto H, limura Y, Yamanishi Y, Yamatsu K. Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-((5,6-dimethoxy-1-oxoindan-2-ye)methyl)piperidine hydrochloride and related compounds. J Med Chem 1995; 38: 4821-9.
-
(1995)
J Med Chem
, vol.38
, pp. 4821-4829
-
-
Sugimoto, H.1
Limura, Y.2
Yamanishi, Y.3
Yamatsu, K.4
-
15
-
-
0031910978
-
Donepezil use in Alzheimer disease
-
Barner EL, Gray SL. Donepezil use in Alzheimer disease. Ann Pharmacother 1998; 32: 70-7.
-
(1998)
Ann Pharmacother
, vol.32
, pp. 70-77
-
-
Barner, E.L.1
Gray, S.L.2
-
16
-
-
0000857096
-
Physiology and pharmacology of the autonomic nervous system
-
Fauci AS, Braunwald E, eds. New York: McGraw-Hill
-
Landsberg L, Young JB. Physiology and pharmacology of the autonomic nervous system. In Fauci AS, Braunwald E, eds. Harrison's principles of internal medicine. New York: McGraw-Hill; 1998. p. 430-42.
-
(1998)
Harrison's Principles of Internal Medicine
, pp. 430-442
-
-
Landsberg, L.1
Young, J.B.2
-
17
-
-
0027230486
-
Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers
-
Mihara M, Ohnishi A, Tomono Y, Hasegawa J, Shimamura Y, Yamazaki K, et al. Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers. Int J Clin Pharmacol Ther Tox 1993; 31: 223-9.
-
(1993)
Int J Clin Pharmacol Ther Tox
, vol.31
, pp. 223-229
-
-
Mihara, M.1
Ohnishi, A.2
Tomono, Y.3
Hasegawa, J.4
Shimamura, Y.5
Yamazaki, K.6
-
18
-
-
0027141935
-
Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly patients
-
Ohnishi A, Mihara M, Kamakura H, Tomono Y, Hasegawa J, Yamazaki K, et al. Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly patients. J Clin Pharmacol 1993; 33: 1086-91.
-
(1993)
J Clin Pharmacol
, vol.33
, pp. 1086-1091
-
-
Ohnishi, A.1
Mihara, M.2
Kamakura, H.3
Tomono, Y.4
Hasegawa, J.5
Yamazaki, K.6
|